Obesity in men: does it affect fertility?
DOI:
https://doi.org/10.47196/diab.v57i3Sup.679Keywords:
obesity, men, fertilityAbstract
It is usual that in the context of seeking pregnancy or during evaluations in a case of infertility, all attention is focused on the pathologies and risk factors of the woman. We forget about the impact of male habits and pathologies and how this impacts the couple's fertility. However, in the evaluation of the infertile couple, a male factor of infertility is detected in 50% of the cases.
Evaluation of the male and treatment in cases of infertility should not be delayed, both members of the infertile couple should be approached together. In cases of seeking pregnancy, without evidence of infertility, it would also be appropriate to advise on healthy habits and treat pathologies, such as obesity, which can affect semen quality.
Obesity can affect male fertility in different ways:
- Increasing oxidative stress.
- Affecting hypothalamic GnRH pulsatility.
- Altering the function of the blood testis barrier.
- Determining less sperm capacitation.
This determines alterations in the quality of the spermogram, sperm DNA damage and subfertility. The treatment of obesity in men improves all these parameters, either through diet and exercise or through pharmacological treatments.
A separate consideration is bariatric surgery in men with a desire for fertility, since there have been reports of cases of impaired sperm count or even azoospermia after it, more evidence is required. The same occurs with metformin treatment in men with obesity and diabetes, where an increased risk of genitourinary malformations has been shown in children born to couples where the father received metformin during the preconception period.
References
I. Costanzo PR, Knoblovits P. Male gonadal axis function in patients with type 2 diabetes. Horm Mol Biol Clin Investig 2016 May 1;26(2):129-34
II. He Z, Yin G, Li QQ, Zeng Q, Duan J. Diabetes mellitus causes male reproductive dysfunction. A review of the evidence and mechanisms. In Vivo 2021 Sep-Oct;35(5):2503-2511.
III. Wensink MJ, Lu Y, Tian L, Shaw GM, Rizzi S, Jensen TK, Mathiesen ER, Skakkebæk NE, Lindahl-Jacobsen R, Eisenberg ML. Preconception antidiabetic drugs in men and birth defects in offspring. A nationwide cohort study. Ann Intern Med 2022 May;175(5):665-673.
IV. La Vignera S, Condorelli RA, Calogero AE, Cannarella R, Aversa A. Sexual and reproductive outcomes in obese fertile men with functional hypogonadism after treatment with liraglutide: preliminary results. J Clin Med. 2023 Jan 14;12(2):672.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 on behalf of the authors. Reproduction rights: Argentine Diabetes Society
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Dirección Nacional de Derecho de Autor, Exp. N° 5.333.129. Instituto Nacional de la Propiedad Industrial, Marca «Revista de la Sociedad Argentina de Diabetes - Asociación Civil» N° de concesión 2.605.405 y N° de disposición 1.404/13.
La Revista de la SAD está licenciada bajo Licencia Creative Commons Atribución – No Comercial – Sin Obra Derivada 4.0 Internacional.
Por otra parte, la Revista SAD permite que los autores mantengan los derechos de autor sin restricciones.